Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Diagnosis and the Role of Genetics

At a Glance

Perry syndrome is suspected from parkinsonism, psychiatric changes, weight loss, and reduced automatic breathing, then supported or confirmed by a disease-causing DCTN1 variant. Genetic counseling helps interpret uncertain results and assess family risk.

Getting a diagnosis of Perry syndrome is often a long and difficult journey. Because it is so rare, it is frequently mistaken for more common conditions [1]. However, understanding how doctors arrive at this diagnosis—and why it might have been missed—can help you advocate for the right tests and the best possible care team.

How a Diagnosis is Made

Experts generally base a clinical diagnosis of Perry syndrome on a compatible clinical picture (phenotype) combined with genetic testing [1]. A diagnosis is typically confirmed when a patient has:

  1. A Compatible Clinical Picture: They show characteristic features such as parkinsonism, psychiatric changes, weight loss, and central hypoventilation [1][2]. (Keep in mind, a patient does not need to have all four symptoms at once for doctors to suspect it).
  2. A Pathogenic Variant: Genetic testing identifies a “pathogenic” or “likely pathogenic” variant in the DCTN1 gene [1].

If a patient has a known family history of the disease alongside movement symptoms and the DCTN1 pathogenic variant, this is also strongly diagnostic [1]. (Sometimes you may read about neuropathologic confirmation involving TDP-43, but this is a postmortem finding from an autopsy, not a routine diagnostic test during life [3]).

Why Misdiagnosis is Common

Perry syndrome is a “great mimicker.” Its symptoms overlap significantly with three other brain disorders, which often leads to it being mislabeled [1]:

  • Parkinson’s Disease (PD): Like PD, Perry syndrome causes stiffness and slowness. However, Perry syndrome usually progresses much faster, often affects both sides of the body equally from the start, and may not respond as well to standard Parkinson’s medications like levodopa [2][4].
  • Progressive Supranuclear Palsy (PSP): This condition also causes movement issues and falls. Some people with Perry syndrome may even have the eye-movement problems typical of PSP, making the two hard to tell apart without genetic testing [5][6].
  • Frontotemporal Dementia (FTD): Because Perry syndrome can cause dramatic personality changes, apathy, or impulsivity, it can look like a behavioral form of dementia [7][8]. The key difference is that Perry syndrome also involves physical symptoms like weight loss and breathing failure [1].

The Role of Genetics and Family History

Perry syndrome is autosomal dominant. This means that if a parent carries a confirmed pathogenic germline variant, each child has a 50% chance of inheriting it, as each pregnancy is an independent risk [9][10]. However, inheritance does not predict the exact age of onset or severity of the disease.

A family history might seem negative for several reasons:

  • Misdiagnosis: A parent or grandparent might have been told they had “typical” Parkinson’s or severe depression [11].
  • Variable Expressivity: Even in the same family, one person might have severe breathing issues while another only has mild movement symptoms [12][13].
  • Age of Onset: Relatives might have passed away from other causes before their symptoms became obvious [13].

If Perry syndrome is suspected, a DCTN1 genetic test is confirmatory only when a pathogenic or likely pathogenic variant is identified [1][14]. A result that shows a “Variant of Uncertain Significance” (VUS) does not confirm the disease, and a negative test may still require expert interpretation to ensure the right parts of the gene were checked. Genetic counseling is highly recommended to interpret these complex results.

What is TDP-43?

A defining neuropathologic characteristic of Perry syndrome is the buildup of a protein called TDP-43 [15]. In a healthy brain, this protein helps manage genetic instructions inside the cell’s nucleus. In Perry syndrome, this protein mislocalizes and clumps together in the wrong parts of the cell [15][16]. While the exact biological pathway is still under study, these TDP-43 clumps are thought to contribute to the dysfunction and loss of neurons in the areas that control movement, mood, and the automatic drive to breathe [16][17].

Common questions in this guide

How is Perry syndrome diagnosed?
Doctors usually diagnose Perry syndrome by matching the person’s symptoms with its characteristic pattern and finding a disease-causing (pathogenic or likely pathogenic) variant in the DCTN1 gene. The pattern may include parkinsonism, psychiatric changes, weight loss, and central hypoventilation, which means reduced automatic breathing; all four features do not need to be present. A compatible family history can further support the diagnosis.
What does a DCTN1 genetic test result mean in Perry syndrome?
A pathogenic or likely pathogenic DCTN1 variant supports or confirms Perry syndrome when the clinical findings fit. A variant of uncertain significance does not confirm the condition, and a negative result may need expert review to check whether the relevant parts of the gene were tested. Genetic counseling can help explain the result and its implications.
Why is Perry syndrome sometimes mistaken for Parkinson’s disease or PSP?
Perry syndrome can resemble Parkinson’s disease, progressive supranuclear palsy, or behavioral frontotemporal dementia because it may cause stiffness, slowness, falls, eye-movement problems, or personality changes. Faster progression, symptoms affecting both sides early, weight loss, breathing failure, and limited benefit from levodopa may provide clues. Genetic testing can help distinguish these conditions.
How is Perry syndrome inherited, and what does it mean for children?
Perry syndrome is autosomal dominant, meaning one altered copy of the DCTN1 gene can cause the condition. If a parent has a confirmed disease-causing germline variant, each child has a 50% chance of inheriting it in each pregnancy. Inheritance does not predict exactly when symptoms will begin or how severe they will be, so genetic counseling is recommended.
Can Perry syndrome be present even if no relative was diagnosed?
Yes. A family history can appear negative if relatives were misdiagnosed with Parkinson’s disease or severe depression, had milder or different symptoms, or died before symptoms became clear. Differences in age of onset can also make the inherited pattern difficult to recognize.
What does TDP-43 have to do with Perry syndrome?
TDP-43 is a protein that can move to the wrong part of brain cells and form clumps in Perry syndrome. These clumps are a defining finding in brain tissue, but they are usually identified at autopsy rather than through a routine test during life. Diagnosis during life relies mainly on the clinical pattern and DCTN1 testing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has my loved one been tested specifically for the DCTN1 gene, and was the result classified as 'pathogenic' or 'likely pathogenic'?
  2. 2.How does our specific clinical presentation (such as the timing of respiratory symptoms) compare to the typical features used for diagnosis?
  3. 3.Could the previous diagnosis of Parkinson's or PSP be re-evaluated in light of the central hypoventilation and psychiatric changes we are seeing?
  4. 4.Since Perry syndrome is autosomal dominant, what are the current recommendations for genetic counseling for our other family members?
  5. 5.Can we coordinate a multi-specialty review including a movement disorder neurologist and a pulmonologist to discuss the diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Establishing diagnostic criteria for Perry syndrome.

    Mishima T, Fujioka S, Tomiyama H, et al.

    Journal of neurology, neurosurgery, and psychiatry 2018; (89(5)):482-487 doi:10.1136/jnnp-2017-316864.

    PMID: 29089398
  2. 2

    Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review.

    Dulski J, Cerquera-Cleves C, Milanowski L, et al.

    European journal of neurology 2021; (28(12)):4010-4021 doi:10.1111/ene.15048.

    PMID: 34342072
  3. 3

    Neuropathology of Perry Syndrome: Evidence of Medullary and Hypothalamic Involvement.

    Kim DD, Alghefari H, Jenkins M, et al.

    Movement disorders clinical practice 2021; (8(5)):713-716 doi:10.1002/mdc3.13235.

    PMID: 34307744
  4. 4

    L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome.

    Dulski J, Cerquera-Cleves C, Milanowski L, et al.

    Parkinsonism & related disorders 2022; (100()):19-23 doi:10.1016/j.parkreldis.2022.05.023.

    PMID: 35691177
  5. 5

    DCTN1 p.K56R in progressive supranuclear palsy.

    Gustavsson EK, Trinh J, Guella I, et al.

    Parkinsonism & related disorders 2016; (28()):56-61.

    PMID: 27132499
  6. 6

    DCTN1 F52L mutation case of Perry syndrome with progressive supranuclear palsy-like tauopathy.

    Honda H, Sasagasako N, Shen C, et al.

    Parkinsonism & related disorders 2018; (51()):105-110 doi:10.1016/j.parkreldis.2018.02.038.

    PMID: 29499916
  7. 7

    Cognitive and behavioral profile of Perry syndrome in two families.

    Milanowski Ł, Sitek EJ, Dulski J, et al.

    Parkinsonism & related disorders 2020; (77()):114-120 doi:10.1016/j.parkreldis.2020.05.019.

    PMID: 32717578
  8. 8

    DCTN1-related neurodegeneration: Perry syndrome and beyond.

    Konno T, Ross OA, Teive HAG, et al.

    Parkinsonism & related disorders 2017; (41()):14-24 doi:10.1016/j.parkreldis.2017.06.004.

    PMID: 28625595
  9. 9

    Perry Disease: Concept of a New Disease and Clinical Diagnostic Criteria.

    Tsuboi Y, Mishima T, Fujioka S

    Journal of movement disorders 2021; (14(1)):1-9 doi:10.14802/jmd.20060.

    PMID: 32942840
  10. 10

    Perry Syndrome with a Novel Mutation and a Rare Presentation: First Report from India.

    Krishnan P, Sarma GRK, Murgod U, et al.

    Annals of Indian Academy of Neurology 2022; (25(4)):703-706 doi:10.4103/aian.aian_890_21.

    PMID: 36211137
  11. 11

    DCTN1-related Parkinson-plus disorder (Perry syndrome).

    Richardson D, McEntagart MM, Isaacs JD

    Practical neurology 2020; (20(4)):317-319 doi:10.1136/practneurol-2020-002505.

    PMID: 32434902
  12. 12

    Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case Series.

    Boardman J, Mascareno Ponte M, Chaouch A, Kobylecki C

    Movement disorders clinical practice 2022; (9(6)):816-820 doi:10.1002/mdc3.13473.

    PMID: 35937488
  13. 13

    Perry syndrome: Novel DCTN1 mutation in a large kindred and first observation of prodromal disease.

    Dulski J, Koga S, Prudencio M, et al.

    Parkinsonism & related disorders 2023; (112()):105481 doi:10.1016/j.parkreldis.2023.105481.

    PMID: 37336025
  14. 14

    A Chinese pedigree with Perry disease caused by the p.Y78H mutation in DCTN1: A 6-year clinical follow-up.

    Pan X, Hong Q, Lu X, et al.

    Behavioural brain research 2023; (441()):114284 doi:10.1016/j.bbr.2023.114284.

    PMID: 36608707
  15. 15

    Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy.

    Mishima T, Koga S, Lin WL, et al.

    Journal of neuropathology and experimental neurology 2017; (76(8)):676-682 doi:10.1093/jnen/nlx049.

    PMID: 28789478
  16. 16

    TDP-43 Cryptic RNAs in Perry Syndrome: Differences across Brain Regions and TDP-43 Proteinopathies.

    Pickles SR, Gonzalez Bejarano J, Narayan A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2025; (40(4)):662-671 doi:10.1002/mds.30104.

    PMID: 39788898
  17. 17

    DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation.

    Deshimaru M, Kinoshita-Kawada M, Kubota K, et al.

    International journal of molecular sciences 2021; (22(8)) doi:10.3390/ijms22083985.

    PMID: 33924373

This page explains Perry syndrome diagnosis, DCTN1 testing, and family inheritance for informational purposes only and does not constitute medical advice. A movement-disorder neurologist and genetic counselor should interpret your specific symptoms and results.

Get notified when new evidence is published on Perry syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.